Design Therapeutics (DSGN) Enterprise Value (2020 - 2021)
Design Therapeutics' Enterprise Value history spans 2 years, with the latest figure at -$393.7 million for Q3 2021.
- For Q3 2021, Enterprise Value changed N/A year-over-year to -$393.7 million; the TTM value through Sep 2021 reached -$393.7 million, changed N/A, while the annual FY2020 figure was -$2.4 million, N/A changed from the prior year.
- Enterprise Value for Q3 2021 was -$393.7 million at Design Therapeutics, down from -$370.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.4 million in Q4 2020 and bottomed at -$400.8 million in Q1 2021.